Genvec Inc (GNVC)

0.59
0.02 3.32
NASDAQ : Health Care
Prev Close 0.61
Open 0.60
Day Low/High 0.59 / 0.60
52 Wk Low/High 0.35 / 3.69
Volume 3.06K
Avg Volume 122.00K
Exchange NASDAQ
Shares Outstanding 22.74M
Market Cap 13.87M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

GenVec Provides Update On Hearing Loss Clinical Program

GenVec Provides Update On Hearing Loss Clinical Program

Data Safety Monitoring Board Recommends Trial Continue

5 Stocks Under $10 Set to Soar Higher

These five stocks trading for less than $10 a share are within range of triggering breakout trades.

GenVec Provides Investor Update

GenVec Provides Investor Update

Highlights Ongoing Initiatives Involving the AdenoVerseā„¢ Gene Delivery Platform

A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks

A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks

Biotech stocks large and small were plummeting as 2016's painful start began to turn torturous.

GenVec Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors

GenVec Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors

Composition of Matter Protection for Proprietary Gorilla Vectors Expansion of AdenoVerseā„¢ Platform Provides Multiple Opportunities for New Applications

GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference

GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference

Presentation Includes Emerging Data from Malaria Collaboration with NIAID

GenVec To Present At 2015 Stem Cell Meeting On The Mesa

GenVec To Present At 2015 Stem Cell Meeting On The Mesa

Wednesday, October 7th, 5:15 pm Pacific/8:15 pm EDT

GenVec To Present At The Jefferies Healthcare Conference

GenVec To Present At The Jefferies Healthcare Conference

Webcast Presentation Scheduled for Thursday, June 4th at 11 a.m. EDT

GenVec To Present At The 27th Annual ROTH Conference

GenVec To Present At The 27th Annual ROTH Conference

Webcast Presentation Scheduled for Monday, March 9th at 12 Noon PST

GenVec To Present At The 17th Annual BIO CEO & Investor Conference

GenVec To Present At The 17th Annual BIO CEO & Investor Conference

Webcast Presentation scheduled for Monday, February 9th at 1:00 p.m. EST

Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium

Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium

Sustained Immune Responses Protecting the Lung and Nose Against RSV Challenge Seen

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Why GenVec (GNVC) Stock Is Up In Aftermarket Trading

Why GenVec (GNVC) Stock Is Up In Aftermarket Trading

Shares of GenVec (GNVC) were up 12.83% to $2.99 in aftermarket trading Thursday.